These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 1513060

  • 1. Survival rate and risk factors for patients with retinoblastoma in Japan. The Committee for the National Registry of Retinoblastoma.
    Jpn J Ophthalmol; 1992; 36(2):121-31. PubMed ID: 1513060
    [Abstract] [Full Text] [Related]

  • 2. [National registry of retinoblastoma in Japan (1975-1982). The Committee for the National Registry of Retinoblastoma].
    Nippon Ganka Gakkai Zasshi; 1992 Nov; 96(11):1433-42. PubMed ID: 1476074
    [Abstract] [Full Text] [Related]

  • 3. Retinoblastoma in Turkey--treatment and prognosis.
    Günalp I, Gündüz K, Arslan Y.
    Jpn J Ophthalmol; 1996 Nov; 40(1):95-102. PubMed ID: 8739506
    [Abstract] [Full Text] [Related]

  • 4. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
    Marees T, Moll AC, Imhof SM, de Boer MR, Ringens PJ, van Leeuwen FE.
    J Natl Cancer Inst; 2008 Dec 17; 100(24):1771-9. PubMed ID: 19066271
    [Abstract] [Full Text] [Related]

  • 5. [Effect of histological criteria (TpNM classification, degree of differentiation) on mortality of patients with retinoblastoma].
    Lommatzsch PK, Morgenstern B.
    Klin Monbl Augenheilkd; 1992 Apr 17; 200(4):284-8. PubMed ID: 1614090
    [Abstract] [Full Text] [Related]

  • 6. Second malignant neoplasms following chemoreduction with carboplatin, etoposide, and vincristine in 245 patients with intraocular retinoblastoma.
    Turaka K, Shields CL, Meadows AT, Leahey A.
    Pediatr Blood Cancer; 2012 Jul 15; 59(1):121-5. PubMed ID: 21826785
    [Abstract] [Full Text] [Related]

  • 7. Histopathologic risk factors in retinoblastoma: a retrospective study of 172 patients treated in a single institution.
    Khelfaoui F, Validire P, Auperin A, Quintana E, Michon J, Pacquement H, Desjardins L, Asselain B, Schlienger P, Vielh P.
    Cancer; 1996 Mar 15; 77(6):1206-13. PubMed ID: 8635145
    [Abstract] [Full Text] [Related]

  • 8. Secondary neoplasms after retinoblastoma treatment: retrospective cohort study of 754 patients in Japan.
    Araki Y, Matsuyama Y, Kobayashi Y, Toyokawa S, Inoue K, Suzuki S, Makimoto A.
    Jpn J Clin Oncol; 2011 Mar 15; 41(3):373-9. PubMed ID: 21051531
    [Abstract] [Full Text] [Related]

  • 9. [Orbital invasion and recurrence of retinoblastoma].
    Zygulska-Machowa H, Maciejewski Z, Sadowska M.
    Klin Oczna; 1991 Jan 15; 93(1):19-20. PubMed ID: 2046280
    [Abstract] [Full Text] [Related]

  • 10. [Retinoblastoma: 21-year review].
    Kayembe L.
    J Fr Ophtalmol; 1986 Jan 15; 9(8-9):561-5. PubMed ID: 3819329
    [Abstract] [Full Text] [Related]

  • 11. Advances in management of retinoblastoma.
    Minoda K.
    Yan Ke Xue Bao; 1992 Mar 15; 8(1):28-33. PubMed ID: 1286678
    [Abstract] [Full Text] [Related]

  • 12. [Risk of metastasis in retinoblastoma].
    Heinrich T, Messmer EP, Höpping W, Havers W, Sauerwein W.
    Klin Monbl Augenheilkd; 1991 Nov 15; 199(5):319-24. PubMed ID: 1787653
    [Abstract] [Full Text] [Related]

  • 13. Second primary tumors in patients with hereditary retinoblastoma: a register-based follow-up study, 1945-1994.
    Moll AC, Imhof SM, Bouter LM, Kuik DJ, Den Otter W, Bezemer PD, Koten JW, Tan KE.
    Int J Cancer; 1996 Aug 07; 67(4):515-9. PubMed ID: 8759610
    [Abstract] [Full Text] [Related]

  • 14. The effect of therapy refusal against medical advice in retinoblastoma patients in a setting where treatment delays are common.
    Sitorus RS, Moll AC, Suhardjono S, Simangunsong LS, Riono P, Imhof S, Völker-Dieben HJ.
    Ophthalmic Genet; 2009 Mar 07; 30(1):31-6. PubMed ID: 19172508
    [Abstract] [Full Text] [Related]

  • 15. Childhood retinoblastoma.
    Nasution R, Sutjipto A.
    Paediatr Indones; 1991 Mar 07; 31(3-4):117-22. PubMed ID: 1956690
    [Abstract] [Full Text] [Related]

  • 16. [Second neoplasms after malignant diseases in childhood].
    Kaatsch P, Michaelis J.
    Klin Padiatr; 1995 Mar 07; 207(4):158-63. PubMed ID: 7564146
    [Abstract] [Full Text] [Related]

  • 17. Retinoblastoma incidence and survival in European children (1978-1997). Report from the Automated Childhood Cancer Information System project.
    MacCarthy A, Draper GJ, Steliarova-Foucher E, Kingston JE.
    Eur J Cancer; 2006 Sep 07; 42(13):2092-102. PubMed ID: 16919773
    [Abstract] [Full Text] [Related]

  • 18. Retinoblastoma in Iran: outcomes in terms of patients' survival and globe survival.
    Naseripour M, Nazari H, Bakhtiari P, Modarres-zadeh M, Vosough P, Ausari M.
    Br J Ophthalmol; 2009 Jan 07; 93(1):28-32. PubMed ID: 18952647
    [Abstract] [Full Text] [Related]

  • 19. [The possibilities for organ-preserving treatment in retinoblastoma in children].
    Belkina BM, Durnov LA, Goldobenko GV.
    Vopr Onkol; 1992 Jan 07; 38(9):1097-103. PubMed ID: 1300824
    [Abstract] [Full Text] [Related]

  • 20. [Fatal outcome of retinoblastoma. Retrospective study of 22 patients].
    Havers W, Höpping W, Schmitt G.
    Helv Paediatr Acta; 1978 Nov 07; 33(4-5):329-39. PubMed ID: 711495
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.